Join the 'Hemangioma' group to help and get support from people like you.
Related terms: Cavernous hemangioma, Strawberry nevus, Infant hemangioma
Posted 18 Feb 2015 by Drugs.com
WEDNESDAY, Feb. 18, 2015 – The heart drug propranolol (Inderal) appears to be effective in treating "strawberry" birthmarks known as infantile hemangiomas, a new study finds. About 3 to 10 percent of infants develop an infantile hemangioma, the researchers say. These red, rubbery-looking growths are caused by the abnormal buildup of blood vessels. Although harmless, they can cause physical and psychological harm, depending on their location. "Propranolol is the first and only medical treatment approved to treat infantile hemangioma," said lead study author Dr. Christine Leaute-Labreze, a pediatric dermatologist at the University of Bordeaux in France. She said the results of her study were key to U.S. Food and Drug Administration approval of propranolol for the treatment of infantile hemangioma in 2014. The drug – a so-called beta-blocker used to treat high blood pressure and angina ... Read more
Posted 18 Mar 2014 by Drugs.com
Castres (Tarn) – France, Parsippany (NJ) – USA, March 17th, 2014 – Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for “proliferating infantile hemangioma requiring systemic therapy”. Hemangeol is an oral solution specially developed for safe and effective use in children. Hemangeol will be available June 2014. This marketing authorization comes after the new drug application for Hemangeol was submitted to the US FDA in May 2013. The application was also submitted to the European Medicines Agency, receiving positive opinion on February 21st, 2014 from the CHMP, with marketing authorization expected for April 28th, 2014. The efficacy of propranolol in the treatment of infantile hemangioma (IH) was first discovered in 2007 by Dr. Christine Léauté-La ... Read more